Phio Pharmaceuticals Corp. (PHIO) stock
PHIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.81−0.00 (-0.17%)
Close on Nov 12, 2026Market cap $9.43MP/E –Yield –
Phio Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
Phio Pharmaceuticals's operating margin for the twelve months ending Dec 31, 2019 was -42795.2%. For fiscal 2019 it was -42795.2%, against -5336.2% the year before. The highest annual figure on record is -5250.4% in fiscal 2013.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | -42795.2% | −37459.0 |
| FY2018 | Dec 31, 2018 | -5336.2% | +88410.4 |
| FY2017 | Dec 31, 2017 | -93746.7% | −46299.3 |
| FY2016 | Dec 31, 2016 | -47447.4% | −17338.5 |
| FY2015 | Dec 31, 2015 | -30108.8% | −24858.4 |
| FY2013 | Dec 31, 2013 | -5250.4% | +8125.9 |
| FY2012 | Dec 31, 2012 | -13376.3% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2019 | Mar 31, 2019 | -10219.0% | +3054.3 |
| Q3 FY2018 | Sep 30, 2018 | -2617.5% | – |
| Q2 FY2018 | Jun 30, 2018 | -3274.1% | – |
| Q1 FY2018 | Mar 31, 2018 | -9734.8% | – |
| Q4 FY2017 | Dec 31, 2017 | -13273.3% | – |
See a number that looks wrong?